Sabre Co. (NASDAQ:SABR) CEO Kurt Joseph Ekert Purchases 65,000 Shares

Sabre Co. (NASDAQ:SABR) CEO Kurt Joseph Ekert bought 65,000 shares of the stock in a transaction on Wednesday, May 8th. The shares were bought at an average price of $2.57 per share, for a total transaction of $167,050.00. Following the acquisition, the chief executive officer now owns 1,155,909 shares in the company, valued at approximately $2,970,686.13. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Sabre Price Performance

NASDAQ:SABR traded up $0.16 during mid-day trading on Thursday, reaching $2.80. The stock had a trading volume of 6,433,588 shares, compared to its average volume of 5,483,022. The company has a market capitalization of $1.07 billion, a price-to-earnings ratio of -1.95 and a beta of 1.69. Sabre Co. has a 1-year low of $1.81 and a 1-year high of $5.76. The stock’s 50 day simple moving average is $2.47 and its two-hundred day simple moving average is $3.41.

Sabre (NASDAQ:SABR) last posted its quarterly earnings results on Thursday, February 15th. The information technology services provider reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.01). The company had revenue of $687.05 million during the quarter, compared to analyst estimates of $707.89 million. Sell-side analysts anticipate that Sabre Co. will post -0.21 EPS for the current fiscal year.

Hedge Funds Weigh In On Sabre

Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Trust Direct Indexing L.P. acquired a new position in Sabre in the first quarter valued at approximately $28,000. Robertson Stephens Wealth Management LLC acquired a new position in Sabre in the third quarter valued at approximately $45,000. Sage Rhino Capital LLC acquired a new position in Sabre in the fourth quarter valued at approximately $45,000. International Assets Investment Management LLC boosted its stake in Sabre by 340.0% in the fourth quarter. International Assets Investment Management LLC now owns 10,846 shares of the information technology services provider’s stock valued at $48,000 after acquiring an additional 8,381 shares during the period. Finally, FDx Advisors Inc. acquired a new position in Sabre in the third quarter valued at approximately $52,000. 89.42% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Bank of America lowered their target price on Sabre from $4.50 to $3.00 and set a “neutral” rating on the stock in a report on Monday, April 15th. Mizuho reduced their target price on Sabre from $4.00 to $3.00 and set a “neutral” rating on the stock in a report on Monday, March 4th. Cantor Fitzgerald initiated coverage on Sabre in a research report on Wednesday, February 21st. They set an “overweight” rating and a $5.00 target price on the stock. Finally, StockNews.com lowered Sabre from a “buy” rating to a “hold” rating in a research report on Friday, April 5th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $4.00.

Sabre Company Profile

Sabre Corporation, together with its subsidiaries, operates as software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates through two segments: Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments.